Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 346-347

  Sookoian, Silvia ^a   Pirola, Carlos J ^a  

^a the Metabolic Syndrome Department of Molecular Genetics and Biology   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ATHEROSCLEROSIS; BODY MASS; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; LETTER; LIPID STORAGE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL HEALTH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHIFT WORKER; WAIST CIRCUMFERENCE;

CAROTID ARTERIES; CAROTID ARTERY DISEASES; FATTY LIVER; HUMANS; MASS SCREENING; OCCUPATIONAL HEALTH; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; WORK SCHEDULE TOLERANCE;

EID: 70450169651     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.008     Document Type: Letter

References (12)

1. Puttonen S, Kivimaki M, Elovainio M, et al. Shift work in young adults and carotid artery intima-media thickness: The Cardiovascular Risk in Young Finns study. Atherosclerosis 2009; epub.
2. Fujino Y., Iso H., Tamakoshi A., et al. A prospective cohort study of shift work and risk of ischemic heart disease in Japanese male workers. Am J Epidemiol 164 (2006) 128-135
3. Knutsson A., Akerstedt T., Jonsson B.G., and Orth-Gomer K. Increased risk of ischaemic heart disease in shift workers. Lancet 2 (1986) 89-92
4. Knutsson A., Hallquist J., Reuterwall C., Theorell T., and Akerstedt T. Shiftwork and myocardial infarction: a case-control study. Occup Environ Med 56 (1999) 46-50
5. Haupt C.M., Alte D., Dorr M., et al. The relation of exposure to shift work with atherosclerosis and myocardial infarction in a general population. Atherosclerosis (2008)
6. Sookoian S., Gemma C., Fernandez G.T., et al. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. J Intern Med 261 (2007) 285-292
7. Targher G., Marra F., and Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 51 (2008) 1947-1953
8. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
9. Sookoian S., and Pirola C.J. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 49 (2008) 600-607
10. Schindhelm R.K., Dekker J.M., Nijpels G., et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 191 (2007) 391-396
11. Sookoian S., Castano G., Burgueno A.L., Gianotti T.F., Rosselli M.S., and Pirola C.J. A diagnostic model to differentiate simple steatosis from nonalcoholic steatohepatitis based on the likelihood ratio form of Bayes theorem. Clin Biochem 42 (2009) 624-629
12. Rosselli MS, Burgueno AL, Carabelli J, Schuman M, Pirola CJ, Sookoian S. Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis (2009); epub.